Carbamate and Pyrethroid Poisoning
On this page
Direct answer
Carbamate and pyrethroid poisoning are two insecticide toxicities with different mechanisms. Carbamates such as carbaryl and carbofuran reversibly inhibit acetylcholinesterase, producing a cholinergic picture that usually settles within a day or two. Pyrethroids such as permethrin and cypermethrin keep nerve sodium channels open, causing paraesthesia and tremor, and they are managed mainly with supportive care rather than atropine.
What you must remember
- Mechanism: carbamates carbamylate acetylcholinesterase reversibly, whereas organophosphates phosphorylate it, so carbamate enzyme activity recovers on its own.
- Cholinergic features: salivation, lacrimation, urination, diarrhoea, emesis, bronchorrhoea, bradycardia, miosis and muscle weakness, with muscarinic signs usually predominant.
- Atropine: the mainstay for muscarinic signs, titrated to dry secretions and a clear chest rather than to a fixed number of doses.
- Pralidoxime: not routinely indicated in carbamate poisoning, because the enzyme reactivates spontaneously and books advise against routine use.
- Duration: carbamate toxicity is usually short-lived, often resolving within 24 to 48 hours, unlike organophosphate poisoning, which can persist and lead to intermediate syndrome.
- Type I pyrethroids: permethrin and similar agents without an alpha-cyano group cause tremor, facial paraesthesia and hyperexcitability.
- Type II pyrethroids: cypermethrin and deltamethrin, which carry an alpha-cyano group, cause choreoathetosis and salivation, the so-called CS syndrome.
- Management: decontaminate the skin, give benzodiazepines for seizures and provide supportive care, since no specific antidote exists for pyrethroids.
Carbamates and pyrethroids compared
The two groups look alike at the bedside but differ in target, antidote and prognosis, which examiners test directly.
| Feature | Carbamates | Pyrethroids |
|---|---|---|
| Molecular target | Acetylcholinesterase, reversibly carbamylated | Voltage-gated sodium channels, held open |
| Typical agents | Carbaryl, aldicarb, carbofuran | Permethrin, cypermethrin, deltamethrin |
| Main features | Muscarinic secretions, bradycardia, miosis, weakness | Facial paraesthesia, tremor, hyperexcitability |
| Atropine | Useful for muscarinic signs | Not indicated |
| Pralidoxime | Not routinely indicated | Not indicated |
| Usual course | Often resolves within 24 to 48 hours | Usually mild; large ingestions may cause seizures |
Muscarinic signs with miosis point to a cholinesterase inhibitor, while paraesthesia without the same autonomic pattern points to a pyrethroid. Type II agents can cause salivation too, so the combination of miosis, bradycardia and bronchorrhoea is a better guide than salivation alone.
History of dermal exposure, the product used and the time course all help separate the two groups. Carbamate patients need observation for recurrent cholinergic signs, while pyrethroid patients mainly need skin decontamination and seizure control. A large ingestion of a concentrated product may still need intensive care, whichever group the poison belongs to.
Where the exam tries to catch you
Most errors come from applying organophosphate reasoning to insecticides that behave differently.
- Trap: giving repeated high-dose pralidoxime to every cholinergic patient Correct: pralidoxime targets organophosphate-inhibited enzyme and is not routine for carbamates.
- Trap: treating pyrethroid paraesthesia with atropine Correct: pyrethroids act on sodium channels, so atropine has no role; decontaminate the skin and treat seizures with benzodiazepines.
- Trap: expecting a prolonged course from carbamate toxicity as in organophosphate poisoning Correct: carbamates usually recover within a day or two, although the patient still needs observation while cholinergic signs persist.
- Trap: assuming salivation always means cholinesterase inhibition Correct: type II pyrethroids such as cypermethrin can cause salivation with choreoathetosis, so look for miosis and bradycardia as well.
Frequently asked questions
Why is atropine used in carbamate poisoning?
Atropine is used in carbamate poisoning to block excess muscarinic acetylcholine at the receptors, which controls bronchorrhoea, bradycardia and salivation. It is titrated to dry secretions and a clear chest, and it treats the symptoms rather than the enzyme.
Is pralidoxime indicated in carbamate poisoning?
Pralidoxime is not routinely indicated in carbamate poisoning, because carbamylated acetylcholinesterase reactivates spontaneously. Its main role is in organophosphate poisoning, where the enzyme is phosphorylated and must be reactivated before ageing occurs.
How do pyrethroids differ from carbamates in their mechanism?
Pyrethroids keep voltage-gated sodium channels open, prolonging nerve firing and causing paraesthesia and tremor. Carbamates instead reversibly inhibit acetylcholinesterase, producing muscarinic and nicotinic cholinergic effects.
What is the treatment for pyrethroid-induced seizures?
Benzodiazepines are the first-line treatment for pyrethroid-induced seizures, alongside supportive care and decontamination of the skin. Atropine and pralidoxime play no role, since pyrethroids do not inhibit cholinesterase.
Which pyrethroids cause choreoathetosis with salivation?
Type II pyrethroids such as cypermethrin and deltamethrin cause choreoathetosis with salivation, a pattern known as CS syndrome. Type I agents such as permethrin cause tremor and paraesthesia instead, which is why history and examination help separate the two types.